Emergence of Klebsiella pneumoniae carbapenemase-producing Proteus mirabilis in Hangzhou, China

Chinese Medical Journal

Volumn 123, Issue 18, 2010, Pages 2568-2570

  Sheng, Zi Ke ^a   Li, Jun Jie ^a   Sheng, Guo Ping ^a   Sheng, Ji Fang ^a   Li, Lan Juan ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Carbapenem; Enterobacteriaceae; Klebsiella pneumoniae carbapenemase; Proteus mirabilis

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE DERIVATIVE; AMPICILLIN; AZTREONAM; CARBAPENEM; CARBAPENEMASE; CEFEPIME; CEFOTAXIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COLISTIN; ERTAPENEM; GENTAMICIN; IMIPENEM; MEROPENEM; PENICILLIN DERIVATIVE; TIGECYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; BLAKPC GENE; CHINA; CONTROLLED STUDY; DISK DIFFUSION; DNA SEQUENCE; EPSILOMETER TEST; ESCHERICHIA COLI; GENE AMPLIFICATION; GENE SEQUENCE; GENETIC TRANSFORMATION; INTENSIVE CARE; KLEBSIELLA PNEUMONIAE; KPC 2 GENE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; POLYMERASE CHAIN REACTION; PROTEUS MIRABILIS; SEQUENCE ANALYSIS; THORAX DRAINAGE;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; CHINA; KLEBSIELLA PNEUMONIAE; PROTEUS MIRABILIS;

EID: 79851498829     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2010.18.014     Document Type: Article

References (16)

1. Yigit H, Queenan AM, Anderson GJ, Domenech-Sanchez A, Biddle JW, Steward CD, et al. Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 2001; 45: 1151-1161.
2. Yigit H, Queenan AM, Rasheed JK, Biddle JW, Domenech-Sanchez A, Alberti S, et al. Carbapenem-resistant strain of Klebsiella oxytoca harboring carbapenemhydrolyzing β-lactamase KPC-2. Antimicrob Agents Chemother 2003; 47: 3881-3889.
3. Navon-Venezia S, Chmelnitsky I, Leavitt A, Schwaber MJ, Schwartz D, Carmeli Y. Plasmid-mediated imipenemhydrolyzing enzyme KPC-2 among multiple carbapenemresistant Escherichia coli clones in Israel. Antimicrob Agents Chemother 2006; 50: 3098-3101.
4. Deshpande LM, Rhomberg PR, Sader HS, Jones RN. Emergence of serine carbapenemases (KPC and SME) among clinical strains of Enterobacteriaceae isolated in the United States medical centers: report from the MYSTIC program (1999-2005). Diagn Microbiol Infect Dis 2006; 56: 367-372.
5. Villegas MV, Lolans K, Correa A, Kattan JN, Lopez JA, Quinn JP, et al. First identification of Pseudomonas aeruginosa isolates producing a KPC type carbapenemhydrolyzing β-lactamase. Antimicrob Agents Chemother 2007; 51: 1553-1555.
6. Miriagou V, Tzouvelekis LS, Rossiter S, Tzelepi E, Angulo FJ, Whichard JM. Imipenem resistance in a Salmonella clinical strain due to plasmid-mediated class A carbapenemase KPC-2. Antimicrob Agents Chemother 2003; 47: 1297-1300.
7. Tibbetts R, Frye JG, Marschall J, Warren D, Dunne W. Detection of KPC-2 in a clinical isolate of Proteus mirabilis and first reported description of carbapenemase resistance caused by a KPC β-lactamase in P. mirabilis. J Clin Microbiol 2008; 46: 3080-3083.
8. Neuwirth C, Siebor E, Duez JM, Pechinot A, Kazmierczak A. Imipenem resistance in clinical isolates of Proteus mirabilis associated with alterations in penicillin-binding proteins. J Antimicrob Chemother 1995; 36: 335-342.
9. Villar HE, Danel F, Livermore DM. Permeability to carbapenems of Proteus mirabilis mutants selected for resistance to imipenem or other beta-lactams. J Antimicrob Chemother 1997; 40: 365-370.
10. Clinical and Laboratory Standards Institute. 2006. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. CLSI document M7-A6. Clinical and Laboratory Standards Institute, Wayne, PA.
11. Lomaestro BM, Tobin EH, Shang W, Gootz T. The spread of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae to upstate New York. Clin Infect Dis 2006; 43: e26-e28.
12. Shibata N, Doi Y, Yamane K, Yagi T, Kurokawa H, Shibayama K, et al. PCR typing of genetic determinants for metallo-β-lactamases and integrases carried by gram-negative bacteria isolated in Japan, with focus on the class 3 integron. J Clin Microbiol 2003; 41: 5407-5413.
13. Wei ZQ, Du XX, Yu YS, Shen P, Chen YG, Li LJ. Plasmid-Mediated KPC-2 in a Klebsiella pneumoniae isolate from China. Antimicrob Agents Chemother 2007; 51: 763-765.
14. Cai JC, Zhou HW, Zhang R, Chen GX. Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli isolates possessing the plasmid-mediated carbapenemhydrolyzing beta-lactamase KPC-2 in intensive care units of a Chinese hospital. Antimicrob Agents Chemother 2008; 52: 2014-2018.
15. Wu Q, Liu Q, Han L, Sun J, Li Y. Plasmid-mediated carbapenem-hydrolyzing enzyme KPC-2 and ArmA 16S rRNA methylase conferring high-level aminoglycoside resistance in carbapenem-resistant Enterobacter cloacae in China. Diagn Microbiol Infect Dis 2010; 66: 326-328.
16. Bratu S, Mooty M, Nichani S, Landman D, Gullans C, Pettinato B, et al. Emergence of KPC-possessing Klebsiella pneumoniae in Brooklyn, New York: epidemiology and recommendations for detection. Antimicrob Agents Chemother 2005; 49: 3018-3020.